About Velaglucerase Alfa
            
            Class: | Enzyme replacement therapy (ERT)  
Use: | Treatment of Type 1 Gaucher disease in patients who have a confirmed diagnosis  
Adult dose: | 60 IU/kg administered every two weeks as an intravenous infusion; may be adjusted based on clinical response  
Pediatric dose: | 60 IU/kg administered every two weeks as an intravenous infusion; dosing may be adjusted based on clinical response  
Side effects: | Headache, nausea, fatigue, infusion-related reactions (e.g., chills, fever), abdominal pain
         
        
            
                
                
                    
                        Drug Class
                    
                    Enzyme replacement therapy (ERT)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of Type 1 Gaucher disease in patients who have a confirmed diagnosis
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; reconstituted solution should be used immediately or stored at 2°C to 8°C for up to 24 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: SHIRE PHARMACEUTICALS IRELAND LIMITED, IRELAND
                    
                    
                    Package Size
                    Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 6680.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        60 IU/kg administered every two weeks as an intravenous infusion; may be adjusted based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        60 IU/kg administered every two weeks as an intravenous infusion; dosing may be adjusted based on clinical response
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, nausea, fatigue, infusion-related reactions (e.g., chills, fever), abdominal pain, and rash
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to velaglucerase alfa or any component of the formulation; caution in patients with a history of severe allergic reactions
         
        
        
            
                Important Warnings
            
            Risk of hypersensitivity reactions; monitor patients for signs of anaphylaxis during and after infusion; patients with a history of severe allergic reactions should be closely monitored; use with caution in patients with cardiac or pulmonary conditions
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.